Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the natural actions of GLP-1, a hormone secreted by the gut in https://privatebookmark.com/story20788247/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes